- Home
- MRKR vs CVR Comparison
MRKR vs CVR Comparison
Compare MRKR & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- CVR
- Stock Information
- Founded
- MRKR N/A
- CVR 1920
- Country
- MRKR United States
- CVR United States
- Employees
- MRKR N/A
- CVR N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- MRKR Health Care
- CVR Industrials
- Exchange
- MRKR Nasdaq
- CVR Nasdaq
- Market Cap
- MRKR 11.6M
- CVR 9.8M
- IPO Year
- MRKR N/A
- CVR N/A
- Fundamental
- Price
- MRKR $0.96
- CVR $9.80
- Analyst Decision
- MRKR Strong Buy
- CVR
- Analyst Count
- MRKR 3
- CVR 0
- Target Price
- MRKR $13.17
- CVR N/A
- AVG Volume (30 Days)
- MRKR 2.7M
- CVR 2.4K
- Earning Date
- MRKR 11-13-2025
- CVR 11-11-2025
- Dividend Yield
- MRKR N/A
- CVR 1.22%
- EPS Growth
- MRKR N/A
- CVR N/A
- EPS
- MRKR N/A
- CVR N/A
- Revenue
- MRKR $5,388,071.00
- CVR $25,617,681.00
- Revenue This Year
- MRKR N/A
- CVR N/A
- Revenue Next Year
- MRKR $15.82
- CVR N/A
- P/E Ratio
- MRKR N/A
- CVR N/A
- Revenue Growth
- MRKR 44.55
- CVR N/A
- 52 Week Low
- MRKR $0.81
- CVR $8.15
- 52 Week High
- MRKR $5.95
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- MRKR 41.99
- CVR 39.76
- Support Level
- MRKR $0.91
- CVR $8.97
- Resistance Level
- MRKR $1.02
- CVR $9.95
- Average True Range (ATR)
- MRKR 0.06
- CVR 0.25
- MACD
- MRKR 0.02
- CVR 0.05
- Stochastic Oscillator
- MRKR 72.00
- CVR 52.20
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.